Compare STRO & LEGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STRO | LEGT |
|---|---|---|
| Founded | 2003 | 2023 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.0M | 278.6M |
| IPO Year | 2018 | 2024 |
| Metric | STRO | LEGT |
|---|---|---|
| Price | $11.08 | $10.84 |
| Analyst Decision | Hold | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $18.29 | N/A |
| AVG Volume (30 Days) | ★ 125.6K | 37.2K |
| Earning Date | 11-06-2025 | 02-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.33 |
| Revenue | ★ $105,646,000.00 | N/A |
| Revenue This Year | $63.08 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $33.00 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.23 | $10.29 |
| 52 Week High | $21.50 | $11.25 |
| Indicator | STRO | LEGT |
|---|---|---|
| Relative Strength Index (RSI) | 78.70 | 50.97 |
| Support Level | $8.49 | $10.82 |
| Resistance Level | $12.00 | $11.14 |
| Average True Range (ATR) | 0.83 | 0.04 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 77.58 | 14.29 |
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
Legato Merger Corp III is a blank check company.